MGC Pharmaceuticals Ltd’s £6.5 Million Listing On The Main Market of The London Stock Exchange plc

Gowling WLG advised Turner Pope Investments Limited, as the broker.

MGC Pharmaceuticals Ltd is a European based and Australian listed bio-pharma company, specialising in the production and development of phytocannabinoid-derived medicines. The listing will make MGC the first medicinal-cannabis company to be admitted to the Main Market of the LSE.

Turner Pope is a boutique stockbroker, providing investment services to corporate and high net worth private clients. Premier Miton and Chelverton Asset Management participated in the fundraising.

Gowling WLG’s legal advisory team comprised of Samantha Myers (Picture – Corporate), Charles Bond (Corporate) Ian Mason (FS Regulation) and John Cooper (Public Law & Regulation).

Involved fees earner: Charles Bond – Gowling WLG; John Cooper – Gowling WLG; Ian Mason – Gowling WLG; Samantha Myers – Gowling WLG;

Law Firms: Gowling WLG;

Clients: Turner Pope Investments Ltd;

Author: Federica Tiefenthaler